Back

Role of sudden cardiac death as end-stage complication in Fabry disease cardiomyopathy: Impact of primary and secondary prophylactic ICD therapy on long-term outcome

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Sudden cardiac death Sudden death / resuscitation ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Daniel Oder

Wuerzburg (Germany)

36 More presentations in this session

Presentation thumbnail
Time-varying circulating biomarkers predict ventricular tachyarrhythmia and death: the LIFEMARKER-VT study
Doctor R. Chong-Yik (New Orleans, US)
Abstract Slides
Presentation thumbnail
Short-term prevalence of fatal ventricular arrhythmic events in patients with newly diagnosed reduced left ventricular ejection fraction
Doctor N. Kikuchi (Shinjyuku, JP)
Abstract
Presentation thumbnail
Surviving at least one year with a good functional status: analysis of the early deaths after primary implantation of intracardiac defibrillator.
Doctor V. Algalarrondo (Paris, FR)
Abstract Slides
Presentation thumbnail
The alliance of forensic pathology and cardiology as a useful approach in the prevention of sudden cardiac death
Doctor S. Garcia Hernandez (Granada, ES)
Abstract Slides
Presentation thumbnail
Preventing premature implantable cardioverter defibrillator therapy (ICD) by using the wearable cardioverter-defibrillator (WCD)
Doctor N. Waessnig (Dresden, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Sudden cardiac death

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources